My Watchlist Items

      No Watchlist
Array ( [0] => stdClass Object ( [symbol] => AXLA [price] => 4.77 [beta] => 0 [volAvg] => 209179 [mktCap] => 179935840 [lastDiv] => 0 [range] => 3.03-6.84 [changes] => -0.18 [companyName] => Axcella Health Inc. [currency] => USD [cik] => 0001633070 [isin] => US05454B1052 [cusip] => 05454B105 [exchange] => Nasdaq Global Market [exchangeShortName] => NASDAQ [industry] => Biotechnology [website] => http://www.axcellahealth.com [description] => Axcella Health, Inc. is a biotechnology company, which engages in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism across a broad spectrum of consumers and patients who have limited options. The company is headquartered in Cambridge, Massachusetts and currently employs 64 full-time employees. The firm focuses on research and development of multifactorial interventions to support health and address dysregulated metabolism across a spectrum of consumers. The company designs and develops endogenous metabolic modulators. Its AXA Development Platform produces a pipeline of AXA candidates with programs in liver, muscle and blood. The Company’s wholly owned pipeline comprises five programs focused on the metabolic functions of the liver, muscle and blood. The company offers AXA1665 for use in treating Hepatic Encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic fatty liver disease; AXA2678 for use in treating immobilization-induced acute muscle atrophy; and AXA4010 to target multiple biological pathways. [ceo] => Mr. William Hinshaw [sector] => Healthcare [country] => US [fullTimeEmployees] => 59 [phone] => 16178680949 [address] => 840 Memorial Dr [city] => Cambridge [state] => MASSACHUSETTS [zip] => 02139 [dcfDiff] => [dcf] => 6.88788 [image] => https://financialmodelingprep.com/image-stock/AXLA.png [ipoDate] => 2019-05-09 [defaultImage] => [isEtf] => [isActivelyTrading] => 1 ) )
Axcella Health Inc. (AXLA)
   4.77   -0.18(-3.64%)
Axcella Health, Inc. is a biotechnology company, which engages in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism across a broad spectrum of consumers and patients who have limited options. The company is headquartered in Cambridge, Massachusetts and currently employs 64 full-time employees. The firm focuses on research and development of multifactorial interventions to support health and address dysregulated metabolism across a spectrum of consumers. The company designs and develops endogenous metabolic modulators. Its AXA Development Platform produces a pipeline of AXA candidates with programs in liver, muscle and blood. The Company’s wholly owned pipeline comprises five programs focused on the metabolic functions of the liver, muscle and blood. The company offers AXA1665 for use in treating Hepatic Encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic fatty liver disease; AXA2678 for use in treating immobilization-induced acute muscle atrophy; and AXA4010 to target multiple biological pathways.
TitleNamePayCurrency PayGenderYear BornTitle Since
Pres of R&D Dr. Alison D. Schecter M.D. N/A USD N/A N/A
Global Head of Regulatory Affairs & Pharmacovigilance and Senior Vice President Dr. Larry Bell N/A USD N/A N/A
Senior Vice President, Chief Legal Officer & Corporation Sec. Dr. Paul Fehlner J.D., Ph.D. N/A USD N/A N/A
Senior Vice President & Chief Financial Officer Mr. Laurent Chardonnet N/A USD male N/A N/A
Pres, Chief Executive Officer & Director Mr. William R. Hinshaw Jr. 785480 USD male 1969 N/A
SymbolDateRatingRating Score Rating Details
AXLA 11 June, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
AXLA 10 June, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
AXLA 9 June, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
AXLA 8 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 7 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 4 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 3 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 2 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 1 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 28 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 27 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 26 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 25 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 24 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 21 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 20 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 19 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 18 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 17 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 14 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 13 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 12 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 11 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 10 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 7 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 6 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 5 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 4 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 3 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 30 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 29 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 28 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 27 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 26 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 23 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 22 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 21 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 20 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 19 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 16 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 15 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 14 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 13 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 12 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 9 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 8 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 7 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 6 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 5 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 1 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 31 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 30 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 29 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 26 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 25 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 24 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 23 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 22 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 19 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 18 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 17 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 16 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 15 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 12 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 11 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 10 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 9 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 8 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 5 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 4 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 3 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 2 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 1 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 26 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 25 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 24 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 23 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 22 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 19 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 18 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 17 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 5 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 4 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 3 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 2 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 1 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 29 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 28 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 27 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 26 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 25 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 22 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 21 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 20 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 19 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 15 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 14 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 13 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 12 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AXLA 11 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HolderSharesDate ReportedChange
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 22760 31 March, 2021 0
JPMORGAN CHASE & CO 29990 31 March, 2021 29990
Global Retirement Partners, LLC 180 31 March, 2021 180
Bank of New York Mellon Corp 85768 31 March, 2021 85768
BANK OF MONTREAL /CAN/ 505 31 March, 2021 -1952
RENAISSANCE TECHNOLOGIES LLC 69087 31 March, 2021 10287
BNP PARIBAS ARBITRAGE, SA 1831 31 March, 2021 -541
AMERICAN INTERNATIONAL GROUP, INC. 9025 31 March, 2021 25
BARCLAYS PLC 12944 31 March, 2021 7946
HighTower Advisors, LLC 10000 31 March, 2021 10000
BANK OF AMERICA CORP /DE/ 21494 31 March, 2021 10045
Artal Group S.A. 712500 31 March, 2021 712500
Hoover Financial Advisors, Inc. 1000 31 March, 2021 1000
JACOBS LEVY EQUITY MANAGEMENT, 129108 31 March, 2021 129108
CHARLES SCHWAB INVESTMENT MANAGEMENT 31128 31 March, 2021 31128
BRIDGEWAY CAPITAL MANAGEMENT, LLC 62467 31 December, 2020 49608
MARSHALL WACE, LLP 60307 31 December, 2020 0
TWO SIGMA INVESTMENTS, LP 48006 31 December, 2020 30241
FIRST TRUST ADVISORS LP 42688 31 December, 2020 -629
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 41610 31 December, 2020 0
GSA CAPITAL PARTNERS LLP 30713 31 December, 2020 30713
SQUAREPOINT OPS LLC 24397 31 December, 2020 -49125
WELLS FARGO & COMPANY/MN 20507 31 December, 2020 4052
MILLENNIUM MANAGEMENT LLC 16146 31 December, 2020 -12344
VIRTU FINANCIAL LLC 15682 31 December, 2020 15682
RUSSELL INVESTMENTS GROUP, LTD. 14195 31 December, 2020 0
MORGAN STANLEY 11675 31 December, 2020 -12140
NEW YORK STATE COMMON RETIREMENT FUND 11000 31 December, 2020 0
DEUTSCHE BANK AG\ 10545 31 December, 2020 2310
INVESCO LTD. 10308 31 December, 2020 10308
RHUMBLINE ADVISERS 10150 31 December, 2020 10150
HIGHTOWER ADVISORS, LLC 10000 31 December, 2020 0
JPMORGAN CHASE & CO 7295 31 December, 2020 -6609
TOWER RESEARCH CAPITAL LLC (TRC) 4590 31 December, 2020 -7287
FLAGSHIP PIONEERING INC. 12548414 31 December, 2020 0
CITIGROUP INC 2817 31 December, 2020 2095
LEGAL & GENERAL GROUP PLC 1809 31 December, 2020 0
HOOVER FINANCIAL ADVISORS, INC. 1000 31 December, 2020 1000
ROYAL BANK OF CANADA 901 31 December, 2020 901
AMERITAS INVESTMENT PARTNERS, INC. 145 31 December, 2020 0
UBS GROUP AG 2949 31 December, 2020 1575
FMR LLC 5631132 31 December, 2020 164102
HARBOURVEST PARTNERS LLC 2807981 31 December, 2020 0
BLACKROCK INC. 1019553 31 December, 2020 41709
VANGUARD GROUP INC 974700 31 December, 2020 3911
ARTAL GROUP S.A. 712500 31 December, 2020 0
GEODE CAPITAL MANAGEMENT, LLC 221026 31 December, 2020 36924
STATE STREET CORP 209288 31 December, 2020 9200
NORTHERN TRUST CORP 189806 31 December, 2020 16839
JACOBS LEVY EQUITY MANAGEMENT, INC 187122 31 December, 2020 -7836
ZACKS INVESTMENT MANAGEMENT 132915 31 December, 2020 -35293
BANK OF NEW YORK MELLON CORP 87116 31 December, 2020 52100
ACADIAN ASSET MANAGEMENT LLC 83983 31 December, 2020 12488
DIMENSIONAL FUND ADVISORS LP 81873 31 December, 2020 18079
NUVEEN ASSET MANAGEMENT, LLC 72227 31 December, 2020 327
LEAP INVESTMENTS LP 10500 30 June, 2020 10500
HolderSharesDate ReportedWeight Percent
DIMENSIONAL FUND ADVISORS LP 124286 31 March, 2021 N/A
NEW YORK STATE COMMON RETIREMENT FUND 11000 31 March, 2021 N/A
iShares Micro-Cap ETF 23719 31 August, 2020 0.02
Vanguard Total Stock Market Index Fund 593458 31 August, 2020 N/A
iShares Russell 2000 ETF 177231 31 August, 2020 N/A
iShares Russell 2000 Growth ETF 82082 31 August, 2020 N/A
Vanguard Extended Market Index Fund 260381 31 July, 2020 N/A
Fidelity Extended Market Index Fund 84237 31 July, 2020 N/A
Fidelity Select Biotechnology Portfolio 538049 31 July, 2020 0.03
Vanguard Russell 2000 Index Fund 12072 31 July, 2020 N/A
Schwab Total Stock Market Index Fund 10482 31 July, 2020 N/A
Fidelity Growth Company K6 Fund 268247 31 July, 2020 0.02
Fidelity Series Growth Company Fund 526039 31 July, 2020 0.02
TIAA-CREF Equity Index Fund 37400 31 July, 2020 N/A
Vanguard Institutional Total Stock Market Index Fund 25793 31 July, 2020 N/A
Fidelity Growth Company Fund 2092900 31 July, 2020 0.02
Schwab Small-Cap Index Fund 20711 31 July, 2020 N/A
Fidelity NASDAQ Composite Index Fund 20100 31 July, 2020 N/A
EQ/2000 Managed Volatility Portfolio 19645 31 July, 2020 N/A
Vanguard Balanced Index Fund 18254 31 July, 2020 N/A
Fidelity Series Total Market Index Fund 16266 31 July, 2020 N/A
TIAA-CREF Small Cap Blend Index Fund 12519 30 June, 2020 N/A
iShares Russell 2000 Small-Cap Index Fund 12271 30 June, 2020 N/A
Bridgeway Ultra-Small Company Market Fund 12859 30 June, 2020 0.05
Fidelity Small Cap Index Fund 43822 30 April, 2020 N/A
SymbolTransaction DateReporting CikSecurities Owned Company CikReporting NameAcquistion Or DispositionForm Type Securities TransactedSecurity NameLink
AXLA 18 May, 2021 0001445826 121172 0001633070 Epstein David R A 4 1534 Common Stock View
AXLA 18 May, 2021 0001445826 15347 0001633070 Epstein David R D 4 1534 Restricted Stock Units View
AXLA 18 April, 2021 0001445826 119638 0001633070 Epstein David R A 4 1535 Common Stock View
AXLA 18 April, 2021 0001445826 16881 0001633070 Epstein David R D 4 1535 Restricted Stock Units View
AXLA 18 March, 2021 0001445826 18416 0001633070 Epstein David R A 4 18416 Restricted Stock Units View
AXLA 18 March, 2021 0001445826 120000 0001633070 Epstein David R A 4 120000 Stock Option (Right to Buy) View
AXLA 17 March, 2021 0001782448 250000 0001633070 Schecter Alison D. A 4 250000 Stock Option (Right to Buy) View
AXLA 9 February, 2021 0001774662 375000 0001633070 Hinshaw William A 4 375000 Stock Option (Right to Buy) View
AXLA 9 February, 2021 0001774663 85000 0001633070 Fehlner Paul A 4 85000 Stock Option (Right to Buy) View
AXLA 9 February, 2021 0001329010 60000 0001633070 Chardonnet Laurent A 4 60000 Restricted Stock Units View
AXLA 9 February, 2021 0001329010 120000 0001633070 Chardonnet Laurent A 4 120000 Stock Option (Right to Buy) View
AXLA 9 February, 2021 0001329010 25000 0001633070 Chardonnet Laurent A 4 25000 Stock Option (Right to Buy) View
AXLA 9 February, 2021 0001774648 102000 0001633070 Chakravarthy Manu A 4 102000 Stock Option (Right to Buy) View
AXLA 9 February, 2021 0001774663 42500 0001633070 Fehlner Paul A 4 42500 Restricted Stock Units View
AXLA 1 February, 2021 0001774648 60000 0001633070 Chakravarthy Manu A 4 60000 Common Stock View
AXLA 1 February, 2021 0001774648 41528 0001633070 Chakravarthy Manu D 4 18472 Common Stock View
AXLA 30 October, 2020 0001329010 6266 0001633070 Chardonnet Laurent A 4 2601 Common Stock View
AXLA 29 September, 2020 0001774662 50000 0001633070 Hinshaw William A 4 50000 Restricted Stock Units View
AXLA 16 September, 2020 0001774663 30000 0001633070 Fehlner Paul A 4 30000 Stock Option (Right to Buy) View
AXLA 8 September, 2020 0001803539 4305541 0001633070 Societe des Produits Nestle S.A. A 4 4305541 Common Stock View
AXLA 1 September, 2020 0001778372 22000 0001633070 Aradhye Shreeram A 4 22000 Stock Option (Right to Buy) View
AXLA 1 August, 2020 0001774648 60000 0001633070 Chakravarthy Manu A 4 60000 Restricted Stock Units View
AXLA 5 June, 2020 0001445826 6800 0001633070 Epstein David R A 4 6800 Stock Option (Right to Buy) View
AXLA 20 May, 2020 0001445826 65000 0001633070 Epstein David R A 4 65000 Stock Option (Right to Buy) View
AXLA 20 May, 2020 0001760669 11000 0001633070 Hoge Stephen A 4 11000 Stock Option (Right to Buy) View
AXLA 20 May, 2020 0001674471 11000 0001633070 Pisano Gary P. A 4 11000 Stock Option (Right to Buy) View
AXLA 20 May, 2020 0001774485 11000 0001633070 Rondinone CRISTINA A 4 11000 Stock Option (Right to Buy) View
AXLA 20 May, 2020 0001555132 11000 0001633070 Sohn Catherine A. A 4 11000 Stock Option (Right to Buy) View
AXLA 20 May, 2020 0001547658 11000 0001633070 Baird William D III A 4 11000 Stock Option (Right to Buy) View
AXLA 20 May, 2020 0001643766 11000 0001633070 Behar Gregory A 4 11000 Stock Option (Right to Buy) View
AXLA 20 May, 2020 0001445826 35000 0001633070 Epstein David R A 4 35000 Stock Option (Right to Buy) View
AXLA 18 May, 2020 0001508051 4808780 0001633070 Flagship Ventures Fund IV General Partner LLC A 4 1520000 Common Stock View
AXLA 18 May, 2020 0001508051 2886023 0001633070 Flagship Ventures Fund IV General Partner LLC A 4 1900000 Common Stock View
AXLA 18 May, 2020 0001644164 4305541 0001633070 Nestle Health Science US Holdings, Inc. A 4 1936842 Common Stock View
AXLA 18 May, 2020 0001508051 1056752 0001633070 Flagship Ventures Fund IV General Partner LLC A 4 380000 Common Stock View
AXLA 18 May, 2020 0001445826 118103 0001633070 Epstein David R A 4 50000 Common Stock View
AXLA 28 February, 2020 0001445826 68103 0001633070 Epstein David R A 4 2005 Common Stock View
AXLA 27 February, 2020 0001445826 66098 0001633070 Epstein David R A 4 12800 Common Stock View
AXLA 31 January, 2020 0001329010 3665 0001633070 Chardonnet Laurent A 4 3000 Common Stock View
AXLA 27 January, 2020 0001329010 665 0001633070 Chardonnet Laurent A 4 352 Common Stock View
AXLA 24 January, 2020 0001329010 313 0001633070 Chardonnet Laurent A 4 313 Common Stock View
AXLA 17 January, 2020 0001555132 1000 0001633070 Sohn Catherine A. A 4 1000 Common Stock View
AXLA 2 January, 2020 0001774662 156700 0001633070 Hinshaw William A 4 156700 Stock Option (Right to Buy) View
AXLA 18 December, 2019 0001774481 45000 0001633070 Tramontin Tony A 4 45000 Stock Option (Right to Buy) View
AXLA 18 December, 2019 0001774519 43000 0001633070 Mitchener Stephen A 4 43000 Stock Option (Right to Buy) View
AXLA 18 December, 2019 0001778372 54500 0001633070 Aradhye Shreeram A 4 54500 Stock Option (Right to Buy) View
AXLA 18 December, 2019 0001329010 72500 0001633070 Chardonnet Laurent A 4 72500 Stock Option (Right to Buy) View
AXLA 18 December, 2019 0001778372 66801 0001633070 Aradhye Shreeram A 4 66801 Restricted Stock Units View
AXLA 18 December, 2019 0001794898 35000 0001633070 King-Jones Heidy A 4 35000 Stock Option (Right to Buy) View
AXLA 18 December, 2019 0001774663 18000 0001633070 Fehlner Paul A 4 18000 Stock Option (Right to Buy) View
AXLA 18 December, 2019 0001774648 41000 0001633070 Chakravarthy Manu A 4 41000 Stock Option (Right to Buy) View
AXLA 27 November, 2019 0001445826 53298 0001633070 Epstein David R A 4 1005 Common Stock View
AXLA 26 November, 2019 0001445826 52293 0001633070 Epstein David R A 4 14000 Common Stock View
AXLA 21 August, 2019 0001445826 35000 0001633070 Epstein David R A 4 35000 Stock Option (Right to Buy) View
AXLA 21 August, 2019 0001445826 65000 0001633070 Epstein David R A 4 65000 Stock Option (Right to Buy) View
AXLA 21 August, 2019 0001555132 22000 0001633070 Sohn Catherine A. A 4 22000 Stock Option (Right to Buy) View
AXLA 2 August, 2019 0001445826 38293 0001633070 Epstein David R A 4 2849 Common Stock View
AXLA 1 August, 2019 0001445826 35444 0001633070 Epstein David R A 4 4092 Common Stock View
AXLA 17 July, 2019 0001445826 31352 0001633070 Epstein David R A 4 1000 Common Stock View
AXLA 10 July, 2019 0001445826 30352 0001633070 Epstein David R A 4 1322 Common Stock View
AXLA 9 July, 2019 0001445826 29030 0001633070 Epstein David R A 4 4200 Common Stock View
AXLA 8 July, 2019 0001445826 24830 0001633070 Epstein David R A 4 274 Common Stock View
AXLA 3 July, 2019 0001445826 19056 0001633070 Epstein David R A 4 56 Common Stock View
AXLA 2 July, 2019 0001445826 19000 0001633070 Epstein David R A 4 3500 Common Stock View
AXLA 1 July, 2019 0001445826 15500 0001633070 Epstein David R A 4 1000 Common Stock View
AXLA 28 June, 2019 0001445826 20000 0001633070 Epstein David R A 4 5400 Common Stock View
AXLA 27 June, 2019 0001445826 14600 0001633070 Epstein David R A 4 100 Common Stock View
AXLA 26 June, 2019 0001445826 14500 0001633070 Epstein David R A 4 14500 Common Stock View
AXLA 22 May, 2019 0001774662 60803 0001633070 Hinshaw William A 4 60803 Stock Option (Right to Buy) View
AXLA 22 May, 2019 0001760669 11000 0001633070 Hoge Stephen A 4 11000 Stock Option (Right to Buy) View
AXLA 22 May, 2019 0001774485 11000 0001633070 Rondinone CRISTINA A 4 11000 Stock Option (Right to Buy) View
AXLA 22 May, 2019 0001547658 11000 0001633070 Baird William D III A 4 11000 Stock Option (Right to Buy) View
AXLA 22 May, 2019 0001643766 11000 0001633070 Behar Gregory A 4 11000 Stock Option (Right to Buy) View
AXLA 22 May, 2019 0001445826 11000 0001633070 Epstein David R A 4 11000 Stock Option (Right to Buy) View
AXLA 22 May, 2019 0001204876 11000 0001633070 BERRY DAVID A A 4 11000 Stock Option (Right to Buy) View
AXLA 22 May, 2019 0001674471 11000 0001633070 Pisano Gary P. A 4 11000 Stock Option (Right to Buy) View
AXLA 13 May, 2019 0001508051 986023 0001633070 Flagship Ventures Fund IV General Partner LLC A 4 500000 Common Stock View
AXLA 13 May, 2019 0001508051 0 0001633070 Flagship Ventures Fund IV General Partner LLC D 4 895255 Series E Preferred Stock View
AXLA 13 May, 2019 0001508051 3288780 0001633070 Flagship Ventures Fund IV General Partner LLC A 4 194409 Common Stock View
AXLA 13 May, 2019 0001508051 628150 0001633070 Flagship Ventures Fund IV General Partner LLC A 4 82324 Common Stock View
AXLA 13 May, 2019 0001508051 3094371 0000320193 Flagship Ventures Fund IV General Partner LLC A 4 335457 Common Stock View
AXLA 13 May, 2019 0001508051 1761029 0000320193 Flagship Ventures Fund IV General Partner LLC A 4 120795 Common Stock View
AXLA 13 May, 2019 0001508051 545826 0000320193 Flagship Ventures Fund IV General Partner LLC A 4 545826 Common Stock View
AXLA 13 May, 2019 0001508051 2758914 0000320193 Flagship Ventures Fund IV General Partner LLC A 4 503840 Common Stock View
AXLA 13 May, 2019 0001508051 486023 0001633070 Flagship Ventures Fund IV General Partner LLC A 4 486023 Common Stock View
AXLA 13 May, 2019 0001508051 676752 0001633070 Flagship Ventures Fund IV General Partner LLC A 4 48602 Common Stock View
AXLA 13 May, 2019 0001508051 1640234 0000320193 Flagship Ventures Fund IV General Partner LLC A 4 209933 Common Stock View
AXLA 13 May, 2019 0001508051 2255074 0000320193 Flagship Ventures Fund IV General Partner LLC A 4 2255074 Common Stock View
AXLA 13 May, 2019 0001508051 1430301 0000320193 Flagship Ventures Fund IV General Partner LLC A 4 751691 Common Stock View
SymbolDatePeriodDownload XLSX File
AXLA 2020 FY Download XLSX File
AXLA 2019 FY Download XLSX File
AXLA 2020 Q4 Download XLSX File
AXLA 2020 Q1 Download XLSX File
AXLA 2020 Q2 Download XLSX File
AXLA 2020 Q3 Download XLSX File
AXLA 2019 Q1 Download XLSX File
AXLA 2019 Q2 Download XLSX File
AXLA 2019 Q3 Download XLSX File
AXLA 2019 Q4 Download XLSX File

Charts

Company Historical Earnings

DateSymbolEPSEPS EstimatedTimeRevenueRevenue Estimated
6 May, 2021 AXLA -0.4 -0.4 bmo 0 0
17 March, 2021 AXLA -0.4 -0.4 bmo 0 0
5 August, 2020 AXLA -0.48 -0.48 bmo 0 0
11 May, 2020 AXLA -0.65 -0.65 bmo 0 0
23 March, 2020 AXLA -0.68 -0.68 bmo 0 0
12 November, 2019 AXLA -0.75 -0.75 bmo 0 0
12 August, 2019 AXLA -0.95 -0.95 bmo 0 0
20 June, 2019 AXLA -2.43 -2.43 bmo 0 0
9 May, 2019 AXLA bmo 0 0

Company Profile

Company Name Axcella Health Inc.
Symbol AXLA
Currency USD
Price 4.77
Exchange Name Nasdaq Global Market (NASDAQ)
Industry Biotechnology
CEO Mr. William Hinshaw
Sector Healthcare
Country US
Full Time Employees 59
Phone 16178680949
Address 840 Memorial Dr
City Cambridge
State MASSACHUSETTS
Zip 02139
>